Search Results

There are 5584 results for: content related to: Neoadjuvant therapy for high-risk bulky regional melanoma

  1. You have full text access to this OnlineOpen article
    CTLA-4 blockade with ipilimumab: biology, safety, efficacy, and future considerations

    Cancer Medicine

    Luis H. Camacho

    Article first published online : 25 JAN 2015, DOI: 10.1002/cam4.371

  2. You have free access to this content
    Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab

    Cancer

    Volume 119, Issue 9, 1 May 2013, Pages: 1675–1682, Jeffrey S. Weber, Reinhard Dummer, Veerle de Pril, Celeste Lebbé, F. Stephen Hodi and for the MDX010-20 Investigators

    Article first published online : 7 FEB 2013, DOI: 10.1002/cncr.27969

  3. You have full text access to this OnlineOpen article
    Model-based clinical pharmacology profiling of ipilimumab in patients with advanced melanoma

    British Journal of Clinical Pharmacology

    Volume 78, Issue 1, July 2014, Pages: 106–117, Yan Feng, Eric Masson, David Dai, Susan M. Parker, David Berman and Amit Roy

    Article first published online : 20 JUN 2014, DOI: 10.1111/bcp.12323

  4. You have full text access to this OnlineOpen article
    Ipilimumab and radiation therapy for melanoma brain metastases

    Cancer Medicine

    Volume 2, Issue 6, December 2013, Pages: 899–906, Ann W. Silk, Michael F. Bassetti, Brady T. West, Christina I. Tsien and Christopher D. Lao

    Article first published online : 10 OCT 2013, DOI: 10.1002/cam4.140

  5. You have free access to this content
    Society for Melanoma Research 2014 Congress

    Pigment Cell & Melanoma Research

    Volume 27, Issue 6, November 2014, Pages: 1169–1241,

    Article first published online : 23 OCT 2014, DOI: 10.1111/pcmr.12317

  6. You have full text access to this OnlineOpen article
    Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting

    Cancer

    Volume 116, Issue 7, 1 April 2010, Pages: 1767–1775, Geoffrey Y. Ku, Jianda Yuan, David B. Page, Sebastian E. A. Schroeder, Katherine S. Panageas, Richard D. Carvajal, Paul B. Chapman, Gary K. Schwartz, James P. Allison and Jedd D. Wolchok

    Article first published online : 8 FEB 2010, DOI: 10.1002/cncr.24951

  7. Molecularly targeted therapies for melanoma

    International Journal of Dermatology

    Volume 52, Issue 5, May 2013, Pages: 523–530, Lucinda S. Liu and Oscar R. Colegio

    Article first published online : 17 APR 2013, DOI: 10.1111/j.1365-4632.2012.05829.x

  8. You have full text access to this OnlineOpen article
    Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery

    Cancer Medicine

    Volume 4, Issue 1, January 2015, Pages: 1–6, Karim Tazi, Amanda Hathaway, Cody Chiuzan and Keisuke Shirai

    Article first published online : 27 AUG 2014, DOI: 10.1002/cam4.315

  9. You have full text access to this OnlineOpen article
    Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma

    Annals of the New York Academy of Sciences

    Volume 1291, Issue 1, July 2013, Pages: 1–13, Jedd D. Wolchok, F. Stephen Hodi, Jeffrey S. Weber, James P. Allison, Walter J. Urba, Caroline Robert, Steven J. O'Day, Axel Hoos, Rachel Humphrey, David M. Berman, Nils Lonberg and Alan J. Korman

    Article first published online : 17 JUN 2013, DOI: 10.1111/nyas.12180

  10. You have free access to this content
    New clinical advances in immunotherapy for the treatment of solid tumours

    Immunology

    Valentina A. Zavala and Alexis M. Kalergis

    Article first published online : 30 MAR 2015, DOI: 10.1111/imm.12459

  11. You have free access to this content
    Clinical activity of ipilimumab for metastatic uveal melanoma

    Cancer

    Volume 119, Issue 20, 15 October 2013, Pages: 3687–3695, Jason J. Luke, Margaret K. Callahan, Michael A. Postow, Emanuela Romano, Nikhil Ramaiya, Mark Bluth, Anita Giobbie-Hurder, Donald P. Lawrence, Nageatte Ibrahim, Patrick A. Ott, Keith T. Flaherty, Ryan J. Sullivan, James J. Harding, Sandra D'Angelo, Mark Dickson, Gary K. Schwartz, Paul B. Chapman, Jedd D. Wolchok, F. Stephen Hodi and Richard D. Carvajal

    Article first published online : 2 AUG 2013, DOI: 10.1002/cncr.28282

  12. You have full text access to this OnlineOpen article
    Is there a role for immune checkpoint blockade with ipilimumab in prostate cancer?

    Cancer Medicine

    Volume 2, Issue 2, April 2013, Pages: 243–252, Edward Cha and Eric J. Small

    Article first published online : 24 FEB 2013, DOI: 10.1002/cam4.64

  13. Developing melanoma therapeutics: overview and update

    Wiley Interdisciplinary Reviews: Systems Biology and Medicine

    Volume 5, Issue 3, May/June 2013, Pages: 257–271, John B. Korman and David E. Fisher

    Article first published online : 13 FEB 2013, DOI: 10.1002/wsbm.1210

  14. Ipilimumab before BRAF inhibitor treatment may be more beneficial than vice versa for the majority of patients with advanced melanoma

    Cancer

    Volume 120, Issue 11, 1 June 2014, Pages: 1617–1619, Paolo A. Ascierto and Kim Margolin

    Article first published online : 27 FEB 2014, DOI: 10.1002/cncr.28622

  15. You have free access to this content
    Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival

    International Journal of Cancer

    Volume 136, Issue 1, 1 January 2015, Pages: 127–137, Alessandra De Remigis, Tanja D. de Gruijl, Jennifer N. Uram, Schey-Cherng Tzou, Shintaro Iwama, Monica V. Talor, Todd D. Armstrong, Saskia J.A.M. Santegoets, Susan F. Slovin, Lei Zheng, Daniel A. Laheru, Elizabeth M. Jaffee, Winald R. Gerritsen, Alfons J.M. van den Eertwegh, Dung T. Le and Patrizio Caturegli

    Article first published online : 28 MAY 2014, DOI: 10.1002/ijc.28973

  16. You have free access to this content
    Ipilimumab-induced toxicities and the gastroenterologist

    Journal of Gastroenterology and Hepatology

    Volume 30, Issue 4, April 2015, Pages: 657–666, Robert Cheng, Adam Cooper, James Kench, Geoff Watson, William Bye, Catriona McNeil and Nicholas Shackel

    Article first published online : 16 MAR 2015, DOI: 10.1111/jgh.12888

  17. You have free access to this content
    Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4)

    Cancer

    Volume 110, Issue 12, 15 December 2007, Pages: 2614–2627, Steven J. O'Day, Omid Hamid and Walter J. Urba

    Article first published online : 14 NOV 2007, DOI: 10.1002/cncr.23086

  18. Melanoma Immunotherapy

    Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

    Volume 77, Issue 6, November/December 2010, Pages: 620–642, Shanthi Sivendran, Bradley Glodny, Michael Pan, Miriam Merad and Yvonne Saenger

    Article first published online : 23 NOV 2010, DOI: 10.1002/msj.20215

  19. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy

    Immunological Reviews

    Volume 224, Issue 1, August 2008, Pages: 141–165, Karl S. Peggs, Sergio A. Quezada and James P. Allison

    Article first published online : 4 AUG 2008, DOI: 10.1111/j.1600-065X.2008.00649.x

  20. You have free access to this content
    Current advances and perspectives in the treatment of advanced melanoma

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 10, Issue 5, May 2012, Pages: 319–325, Elisabeth Livingstone, Lisa Zimmer, Julia Vaubel and Dirk Schadendorf

    Article first published online : 20 MAR 2012, DOI: 10.1111/j.1610-0387.2012.07895.x